Gin Hwa Biotech (ROCO:7806) Common Stock: NT$278.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7806 Gin Hwa Biotech Inc ROCO:7806
22 GF Score
Price NT$61.90
! 2 Warning Signs
View Full Analysis

What is Gin Hwa Biotech Common Stock?

Gin Hwa Biotech ROCO:7806 22 Common Stock is NT$278.6 Mil as of Dec. 2025. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Gin Hwa Biotech's quarterly common stock stayed the same from Dec. 2024 (NT$238.6 Mil) to Jun. 2025 (NT$238.6 Mil) but then increased from Jun. 2025 (NT$238.6 Mil) to Dec. 2025 (NT$278.6 Mil).

Gin Hwa Biotech's annual common stock increased from Dec. 2023 (NT$149.0 Mil) to Dec. 2024 (NT$238.6 Mil) and increased from Dec. 2024 (NT$238.6 Mil) to Dec. 2025 (NT$278.6 Mil).

Gin Hwa Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for Gin Hwa Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gin Hwa Biotech Common Stock Chart

Gin Hwa Biotech Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
106.92 149.00 238.60 278.60

Gin Hwa Biotech Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 149.00 208.60 238.60 238.60 278.60
ROCO:7806
22GF Score
Gin Hwa Biotech Inc ROCO:7806
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gin Hwa Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$278.6 Mil mean?
Gin Hwa Biotech (ROCO:7806) has a Common Stock of NT$278.6 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gin Hwa Biotech and its competitors.
Is Gin Hwa Biotech's Common Stock too high?
Gin Hwa Biotech's current Common Stock is NT$278.6 Mil. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's Common Stock compare to VRTX and REGN?
Gin Hwa Biotech's Common Stock of NT$278.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current Common Stock is NT$278.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current Common Stock of NT$278.6 Mil. The current Common Stock is NT$278.6 Mil. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current Common Stock is NT$278.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gin Hwa Biotech Business Description

Address No. 5, Guangming 7th Lane, Weixin Road, 1st Floor, Yong'an District, Kaohsiung, TWN, 828
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score

Get the complete analysis for ROCO:7806

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.90
Price